If your gums bleed when you brush, if your dentist has flagged deep pockets around your teeth, or if early tooth loss runs in your family, this test goes a layer deeper than a standard cleaning can. It checks your saliva for a specific bacterium that quietly drives some of the most aggressive gum infections and has been linked, in human studies, to a roughly two-fold increase in the odds of stable coronary artery disease.
Aa (Aggregatibacter actinomycetemcomitans) is not a hormone or a metabolite. It is a living organism, and its presence in your mouth is meaningful because of what it does once it gets a foothold. Knowing whether you carry it, and how much, gives you a head start on protecting both your teeth and the rest of your body.
Aa is a Gram-negative coccobacillus, a tiny rod-shaped microbe that hides in the plaque under your gumline. Its danger comes from two main weapons. The first is a poison called leukotoxin (a toxin that specifically targets white blood cells), which binds to your immune cells and kills them. The second is a damaging compound called cytolethal distending toxin, which freezes the growth cycle of immune cells and chips away at the protective lining of your gums.
When this microbe colonizes the space between your gum and tooth, it does more than cause local irritation. It rebalances the entire community of bacteria in your mouth toward an inflammatory, tissue-destroying mix. One particularly aggressive strain, called JP2, carries a genetic deletion that makes it produce far more leukotoxin than the typical strain, which is why people who carry it tend to lose attachment around their teeth faster.
The clearest link is to a condition once called localized aggressive periodontitis and now classified as Localized Stage III Grade C periodontitis. This is the form of gum disease that strikes teenagers and young adults, often with little plaque visible to the eye, and that can destroy the bone around the front teeth and first molars within a few years.
In a long-term study that followed 1,075 initially healthy adolescents, detecting Aa in periodontally healthy children acted as a risk marker for the later development of aggressive periodontitis. A separate study of 258 African-American adolescents found that the combination of Aa with two other oral bacteria, Streptococcus parasanguinis and Filifactor alocis, present together at a site predicted future bone loss at that exact location. In Moroccan adolescents, high salivary levels of the JP2 strain were tightly linked to clinical attachment loss, where the gum and bone pull away from the tooth.
What this means for you: a positive saliva result, especially with the JP2 strain, is not just an academic curiosity. It is a signal that the biological machinery for fast gum and bone destruction may be in place, even if your gums look acceptable today.
Oral Aa does not stay in your mouth. The bacterium and the antibodies your body makes against it can be measured in the bloodstream, and several large human studies have linked both to heart problems.
In 445 adults who had detailed dental and cardiac assessments, finding Aa under the gumline was associated with nearly twice the risk of stable coronary artery disease (narrowed heart arteries), and that link held independent of bone loss. In a separate analysis of 492 cardiac patients, high salivary levels of Aa were associated with both stable and acute coronary artery disease. A prospective study of 1,023 men found that high serum antibodies against Aa predicted future coronary heart disease, and a meta-analysis combining multiple studies confirmed that elevated antibody responses to periodontal bacteria, including Aa, are linked to higher coronary heart disease risk.
Most of these heart-disease findings come from studies that measured Aa in subgingival plaque under the gum or as antibodies in blood, not saliva. The salivary test offers a related but not identical read on your oral burden of this organism. Treat a positive saliva result as a reason to look harder at both your gums and your cardiovascular markers, not as a direct prediction of a heart attack.
Aa has emerged as a candidate trigger for rheumatoid arthritis (RA), the autoimmune disease that attacks joints. In a study of 115 people with periodontitis and RA, Aa infection was associated with the development of gum disease in patients with the joint condition. A documented case showed that antibiotic treatment of an Aa infection resolved RA-associated autoimmunity in one patient. However, a larger study of 102 people at increased risk of RA found that antibodies to leukotoxin from Aa were not consistently predictive of who would develop the disease, so the relationship remains under active investigation.
Beyond joints and arteries, Aa belongs to a group of mouth-and-throat bacteria capable of causing infective endocarditis (infection of the heart valves), and case reports describe it triggering pneumonia, lung pus collections, and brain abscesses, especially when it escapes the mouth in vulnerable people. One study connected high blood antibody responses to Aa with the formation and rupture of brain aneurysms, though that work is preliminary.
Salivary Aa testing is a research-grounded but still emerging clinical tool, and there are no universally agreed cutpoints for what counts as a low, moderate, or high carriage level. Different labs use different molecular methods, so the numerical scale on your report is best interpreted by the issuing lab, not against an outside standard.
The ranges below come from descriptive cross-sectional studies of adolescents and adults rather than from formal clinical guidelines. They are illustrative orientation, not personal targets. Your lab will likely report different numbers.
| Result | What It Generally Suggests | Who Was Studied |
|---|---|---|
| Aa not detected | Consistent with a healthier oral microbial balance; in a longitudinal study, no Aa-negative adolescents developed bone loss over follow-up. | African-American adolescents followed for years before bone loss developed |
| Aa detected, low-to-moderate load | Carriage that may not yet have caused damage but represents a real risk marker for future attachment loss. | 1,075 initially healthy adolescents tracked over time |
| Aa detected, high load or JP2 strain | Stronger association with active clinical attachment loss and aggressive periodontitis; the JP2 strain produces far more leukotoxin than typical strains. | Moroccan adolescents with subgingival JP2 carriage and global JP2 systematic review |
Compare your results within the same lab over time for the most meaningful trend. A single positive result does not equal a periodontitis diagnosis, and a single negative does not guarantee future gum health.
A few practical things can throw off a salivary Aa result, sometimes in either direction.
A single salivary Aa reading is a snapshot, not a diagnosis. The bacterium can fluctuate with cleanings, sickness, stress, and changes in your oral care routine. Serial testing is what turns the number into useful information, because it shows you whether your interventions are working.
If you are starting from a positive result, get a baseline now, repeat in three to six months if you are making changes such as professional treatment, daily flossing, or probiotic use, and then retest at least once a year. A six-year periodontal maintenance study of 73 patients found that long-term care could lower Aa loads even when the more virulent strains were harder to remove, showing that follow-up matters more than a one-time score.
A detectable Aa result, particularly at high levels or with the JP2 strain, is best treated as a prompt to act rather than panic. Reasonable next steps include a full periodontal exam with probing depths and bleeding scores, a dental imaging review for early bone loss, and a conversation with a periodontist if any pockets measure 5 mm or deeper. Because of the heart-disease link, it is also a sensible moment to check standard cardiovascular markers such as ApoB (a measure of the cholesterol particles that build plaque), Lp(a) (lipoprotein little a, an inherited heart-risk marker), and hs-CRP (high-sensitivity C-reactive protein, a marker of low-grade inflammation in the body).
If you also have rheumatoid arthritis or strong autoimmune symptoms, share your result with your rheumatologist. The science here is unsettled, but treating documented oral infections has, in some cases, improved systemic inflammation.
Evidence-backed interventions that affect your Aggregatibacter actinomycetemcomitans level
Aggregatibacter actinomycetemcomitans is best interpreted alongside these tests.